Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
ALNY holding history
Alnylam Pharmaceuticals, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −35,406−100.0% | Sold out | Holders |
| Q4 2025 | 35,406 | $14.1M | <0.1% | −31,814−47.3% | Reduced | Holders |
| Q3 2025 | 67,220 | $30.7M | 0.1% | +67,220 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −523,972−100.0% | Sold out | Holders |
| Q4 2022 | 523,972 | $124.5M | 0.4% | +4,840+0.9% | Added | Holders |
| Q3 2022 | 519,132 | $103.9M | 0.4% | +519,132 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −42,000−100.0% | Sold out | Holders |
| Q4 2021 | 42,000 | $7.12M | <0.1% | −238,000−85.0% | Reduced | Holders |
| Q3 2021 | 280,000 | $52.9M | 0.1% | +280,000 | New | Holders |